|
|
|
|
Asenapine, Olanzapine Effective in Patients With Bipolar 1 Disorder: Presented at WCBP
-- Asenapine and olanzapine lessen the severity of acute manic symptoms in patients with bipolar 1 disorder who have either manic or mixed episodes, researchers reported on July 2 here at the 9th World Congress of...
|
|
|
Asenapine, Olanzapine Effective in Patients With Bipolar 1 Disorder: Presented at WCBP
-- Asenapine and olanzapine lessen the severity of acute manic symptoms in patients with bipolar 1 disorder who have either manic or mixed episodes, researchers reported on July 2 here at the 9th World Congress of...
|
|
|
Global Multi-Site Study Comparing Medications for Bipolar Disorder to be Presented at International Conference
People with bipolar disorder stay free of symptoms longer when they are treated with a combination of mood stabilizing drugs rather than just one, according to an international research study.Using both lithium and divalproex...
|
|
|
Doctors Diagnosing Bipolar Disorder In Children Should Consider Irritability A Symptom, Study
New research from the US adds to mounting evidence that when diagnosing bipolar disorder in children doctors and clinicians should consider irritability as a possible symptom.The study, by researchers at the Bradley Hospital and The...
|
|
|
Study Suggests Irritability Should Be Considered When Diagnosing Bipolar Disorder in Children
-- A study published in the July issue of the Journal of the American Academy of Child and Adolescent Psychiatry adds to mounting evidence that clinicians consider irritability as a symptom when diagnosing paediatric bipolar disorder....
|
|
|
Childhood Onset Major Depressive Disorder: Course of Illness and Psychiatric Comorbidity in a Community Sample
Today in Child/Adolescent Psych...Childhood Onset Major Depressive Disorder: Course of Illness and Psychiatric Comorbidity in a Community Sample.
|
|
|
Irritability Should Be Considered When Diagnosing Bipolar Disorder In Children
A new study from Bradley Hospital and The Warren Alpert Medical School of Brown University, as well as two other institutions, adds to mounting evidence that clinicians consider irritability as a symptom when diagnosing pediatric bipolar...
|
|
|
Par Pharmaceutical Begins Shipment of Generic Risperdal M-TAB
/PRNewswire-FirstCall/ -- Par Pharmaceutical Companies, Inc.today announced that it began shipping 0.25 mg, 3 mg and 4 mg strengths of risperidone ODT to the trade. Risperidone ODT is a generic version of Janssen Pharma's Risperdal(R) M...
|
|
|
Health Highlights: June 5, 2009
FDA Considers New Psychiatric Drugs for Children Susan Boyle Leaves Mental Health Clinic Puerto Rico Has High HIV Infection Rate: Study Big Differences Among States in Drug Abuse, Mental Illness: Report Here are some of the latest...
|
|
|
Par Pharmaceutical Begins Shipment Of Generic Risperdal® M-TAB
Woodcliff Lake, N.J /PRNewswire-FirstCall/ -- Par Pharmaceutical Companies, Inc.(NYSE: PRX) today announced that it began shipping 0.25 mg, 3 mg and 4 mg strengths of risperidone ODT to the trade. Risperidone ODT is a generic version of...
|
|
|
Par Pharmaceutical, Inc. Begins Shipment of Generic Risperdal(R) M-TAB
WOODCLIFF LAKE, N.J., June 2 /PRNewswire-FirstCall/ -- Par Pharmaceutical Companies, Inc.today announced that it began shipping 0.25 mg, 3 mg and 4 mg strengths of risperidone ODT to the trade. Risperidone ODT is a generic version of...
|
|
|
Par Pharmaceutical Begins Shipment of Generic Risperdal(R) M-TAB
WOODCLIFF LAKE, N.J., June 2 /PRNewswire-FirstCall/ -- Par Pharmaceutical Companies, Inc.today announced that it began shipping 0.25 mg, 3 mg and 4 mg strengths of risperidone ODT to the trade. Risperidone ODT is a generic version of...
|
|
|
Par Pharmaceutical Begins Shipment of Generic Risperdal(R) M-TAB
Par Pharmaceutical Companies, Inc.today announced that it began shipping 0.25 mg, 3 mg and 4 mg strengths of risperidone ODT to the trade. Risperidone ODT is a generic version of Janssen Pharma's Risperdal(R) M-TAB. Annual U.S.
|
|
|
Par Pharmaceutical Begins Shipment of Generic Risperdal(R) M-TAB
WOODCLIFF LAKE, N.J., June 2 /PRNewswire-FirstCall/ -- Par Pharmaceutical Companies, Inc.(NYSE: PRX) today announced that it began shipping 0.25 mg, 3 mg and 4 mg strengths of risperidone ODT to the trade. Risperidone ODT is a generic...
|
|
|
Par Pharmaceutical Begins Shipment of Generic Risperdal(R) M-TAB
WOODCLIFF LAKE, N.J., June 2 /PRNewswire-FirstCall/ -- Par Pharmaceutical Companies, Inc.(NYSE: PRX - News) today announced that it began shipping 0.25 mg, 3 mg and 4 mg strengths of risperidone ODT to the trade. Risperidone ODT is a...
|
|
|
Par Pharmaceutical Begins Shipment of Generic Risperdal(R) M-TAB
Related: WOODCLIFF LAKE, N.J., June 2 /PRNewswire-FirstCall/ -- Par Pharmaceutical Companies, Inc.(NYSE: PRX - News) today announced that it began shipping 0.25 mg, 3 mg and 4 mg strengths of risperidone ODT to the trade. Risperidone...
|
|
|
GlaxoSmithKline Receives FDA Nod for Lamictal XR as Once-Daily Add-On Epilepsy Therapy - Update
(RTTNews) - Drug maker GlaxoSmithKline (GSK) Monday said its epilepsy drug Lamictal XR has been approved by the US Food and Drug Administration, as a once-a-day add-on therapy for adult and adolescent patients, who still experience seizures...
|
|
|
Awareness in bipolar I disorder linked to brain atrophy
MedWire News: In bipolar I disorder patients, both general and symptom awareness are associated with brain atrophy, but not with neurofunctioning, Norwegian researchers have discovered.Previous studies have indicated that insight is...
|
|
|
GlaxoSmithKline Receives FDA Nod for Lamictal XR as Once-Daily Add-On Epilepsy Therapy - Update
Drug maker GlaxoSmithKline (GSK: News ) Monday said its epilepsy drug Lamictal XR has been approved by the US Food and Drug Administration, as a once-a-day add-on therapy for adult and adolescent patients, who still experience seizures with...
|
|
|
GlaxoSmithKline Receives FDA Nod for Lamictal XR as Add-On Epilepsy Therapy
PM ET RELATED NEWS TOP MARKET NEWS (RTTNews) - Drug maker GlaxoSmithKline (GSK: News ) Monday said its epilepsy drug Lamictal XR has been approved by the US Food and Drug Administration, as a once-a-day add-on therapy for adult and...
|
|
|
GlaxoSmithKline Receives FDA Nod for Lamictal XR as Once-Daily Add-On Epilepsy Therapy - Update
(RTTNews) - Drug maker GlaxoSmithKline (GSK | Quote | Chart | News | PowerRating) Monday said its epilepsy drug Lamictal XR has been approved by the US Food and Drug Administration, as a once-a-day add-on therapy for adult and adolescent...
|
|
|
Janssen gets FDA nod to use risperidone as monotherapy, adjunctive therapy in bipolar I disorder
Janssen, Division of Ortho-McNeil-Janssen Pharmaceuticals Inc has received US Food and Drug Administration (FDA) approval for Supplemental New Drug Applications (sNDAs) for the use of Risperdal Consta (risperidone) Long-Acting Treatment as...
|
|
|
New National Online Survey Says Bipolar Depressive Symptoms Have Impact on Day-To-Day Tasks as Well as Social
WASHINGTON, April 17 /PRNewswire/ -- A new national online survey of more than 2,000 people living with bipolar disorder and 500 physicians who treat patients with bipolar disorder identified that the greatest concern among...
|
